Literature DB >> 12517931

Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein.

Satoshi Takaki1, Yoshinari Tezuka, Karsten Sauer, Chiyomi Kubo, Sang-Mo Kwon, Erin Armstead, Kazuki Nakao, Motoya Katsuki, Roger M Perlmutter, Kiyoshi Takatsu.   

Abstract

Lnk is an adaptor protein expressed primarily in lymphocytes and hemopoietic precursor cells. Marked expansion of B lineage cells occurs in lnk(-/-) mice, indicating that Lnk regulates B cell production by negatively controlling pro-B cell expansion. In addition, lnk(-/-) hemopoietic precursors have an advantage in repopulating the hemopoietic system of irradiated host animals. In this study, we show that Lnk overexpression results in impaired expansion of lymphoid precursor cells and altered mature B cell subpopulations. The representation of both B lineage and T lineage cells was reduced in transgenic mice overexpressing Lnk under the control of a lymphocyte-specific expression vector. Whereas the overall number of B and T cells was correlated with Lnk protein expression levels, marginal zone B cells in spleen and B1 cells in the peritoneal cavity were relatively resistant to Lnk overexpression. The C-terminal tyrosine residue, conserved among Lnk family adaptor proteins, was dispensable for the negative regulatory roles of Lnk in lymphocyte development. Our results illuminate the novel negative regulatory mechanism mediated by the Lnk adaptor protein in controlling lymphocyte production and function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517931     DOI: 10.4049/jimmunol.170.2.703

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Increased numbers of B-1 cells and enhanced responses against TI-2 antigen in mice lacking APS, an adaptor molecule containing PH and SH2 domains.

Authors:  Masanori Iseki; Chiyomi Kubo; Sang-Mo Kwon; Akiko Yamaguchi; Yuki Kataoka; Nobuaki Yoshida; Kiyoshi Takatsu; Satoshi Takaki
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

2.  Adaptor protein Lnk inhibits c-Fms-mediated macrophage function.

Authors:  Saskia Gueller; Helen S Goodridge; Birte Niebuhr; Hongtao Xing; Maya Koren-Michowitz; Hubert Serve; David M Underhill; Christian H Brandts; H Phillip Koeffler
Journal:  J Leukoc Biol       Date:  2010-06-22       Impact factor: 4.962

3.  LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.

Authors:  Julie Devallière; Mathias Chatelais; Juliette Fitau; Nathalie Gérard; Philippe Hulin; Laura Velazquez; Christopher E Turner; Béatrice Charreau
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

Review 4.  Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia.

Authors:  Noa Tal; Chen Shochat; Ifat Geron; Dani Bercovich; Shai Izraeli
Journal:  Cell Mol Life Sci       Date:  2013-04-27       Impact factor: 9.261

5.  Genetic loss of SH2B3 in acute lymphoblastic leukemia.

Authors:  Arianne Perez-Garcia; Alberto Ambesi-Impiombato; Michael Hadler; Isaura Rigo; Charles A LeDuc; Kara Kelly; Chaim Jalas; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Martin S Tallman; Maddalena Paganin; Giuseppe Basso; Wei Tong; Wendy K Chung; Adolfo A Ferrando
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

6.  Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.

Authors:  Wei Tong; Jing Zhang; Harvey F Lodish
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

7.  SH2B3 (LNK) as a novel link of immune signaling, inflammation, and hypertension in Dahl salt-sensitive hypertensive rats.

Authors:  Jia L Zhuo
Journal:  Hypertension       Date:  2015-03-16       Impact factor: 10.190

8.  Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation.

Authors:  Nathan P Rudemiller; Hayley Lund; Jessica R C Priestley; Bradley T Endres; Jeremy W Prokop; Howard J Jacob; Aron M Geurts; Eric P Cohen; David L Mattson
Journal:  Hypertension       Date:  2015-03-16       Impact factor: 10.190

9.  Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.

Authors:  Wei Tong; Harvey F Lodish
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

10.  Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders.

Authors:  Sigal Gery; Saskia Gueller; Katya Chumakova; Norihiko Kawamata; Liqin Liu; H Phillip Koeffler
Journal:  Blood       Date:  2007-08-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.